Manik Chatterjee

4.2k total citations
87 papers, 2.7k citations indexed

About

Manik Chatterjee is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Manik Chatterjee has authored 87 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 38 papers in Hematology and 26 papers in Oncology. Recurrent topics in Manik Chatterjee's work include Multiple Myeloma Research and Treatments (38 papers), Protein Degradation and Inhibitors (12 papers) and Heat shock proteins research (12 papers). Manik Chatterjee is often cited by papers focused on Multiple Myeloma Research and Treatments (38 papers), Protein Degradation and Inhibitors (12 papers) and Heat shock proteins research (12 papers). Manik Chatterjee collaborates with scholars based in Germany, United States and Switzerland. Manik Chatterjee's co-authors include Ralf C. Bargou, Thorsten Stühmer, Hermann Einsele, Kurt Bommert, Bernd Dörken, Torsten Steinbrunn, Mindaugas Andrulis, Pia Herrmann, Andreas Rosenwald and Stephan Mathas and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Manik Chatterjee

84 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manik Chatterjee Germany 32 1.7k 880 844 424 267 87 2.7k
Jian Hou China 30 1.7k 1.0× 1.1k 1.3× 1.1k 1.3× 634 1.5× 172 0.6× 154 2.9k
A Levitzki Israel 21 1.8k 1.0× 395 0.4× 1.1k 1.3× 450 1.1× 181 0.7× 26 3.1k
Masaki Ri Japan 24 1000 0.6× 461 0.5× 576 0.7× 446 1.1× 200 0.7× 117 1.9k
Christin Tse United States 22 3.5k 2.0× 375 0.4× 882 1.0× 415 1.0× 298 1.1× 24 4.3k
Anna Scuto United States 19 1.4k 0.8× 301 0.3× 667 0.8× 462 1.1× 257 1.0× 30 2.2k
Stephen K. Tahir United States 22 2.4k 1.4× 337 0.4× 980 1.2× 391 0.9× 308 1.2× 35 3.3k
Frank D. Böhmer Germany 25 2.2k 1.2× 534 0.6× 619 0.7× 825 1.9× 149 0.6× 47 3.2k
Florian Grebien Austria 25 1.3k 0.7× 793 0.9× 450 0.5× 323 0.8× 97 0.4× 62 2.4k
Paul Nimmer United States 8 1.8k 1.0× 344 0.4× 665 0.8× 315 0.7× 221 0.8× 11 2.4k
Mariateresa Fulciniti United States 34 2.6k 1.5× 1.4k 1.6× 1.5k 1.8× 638 1.5× 375 1.4× 155 4.1k

Countries citing papers authored by Manik Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Manik Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manik Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manik Chatterjee more than expected).

Fields of papers citing papers by Manik Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manik Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manik Chatterjee. The network helps show where Manik Chatterjee may publish in the future.

Co-authorship network of co-authors of Manik Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Manik Chatterjee. A scholar is included among the top collaborators of Manik Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manik Chatterjee. Manik Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deschler-Baier, Barbara, Matthias Kroiß, Manik Chatterjee, et al.. (2024). Rapid response to selpercatinib in RET fusion positive pancreatic neuroendocrine carcinoma confirmed by smartwatch. npj Precision Oncology. 8(1). 167–167.
2.
Wermke, Martin, Sebastian Ochsenreither, Manik Chatterjee, et al.. (2024). 1001MO Initial safety, pharmacokinetics, and anti-tumor activity data of TCER IMA401, a MAGEA4/8-directed half-life extended TCR bispecific, in phase I dose escalation. Annals of Oncology. 35. S681–S682. 2 indexed citations
3.
Brünnert, Daniela, Pankaj Goyal, Doris Feineis, et al.. (2023). Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate. Pharmaceuticals. 16(8). 1181–1181. 2 indexed citations
4.
Boulos, Joelle C., Manik Chatterjee, Letian Shan, & Thomas Efferth. (2023). In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia. Cancers. 15(16). 4136–4136. 8 indexed citations
5.
Saeed, Mohamed E.M., Joelle C. Boulos, Ellen Leich, et al.. (2022). Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells. Cancer Genomics & Proteomics. 19(5). 540–555. 8 indexed citations
6.
Boulos, Joelle C., Mohamed E.M. Saeed, Manik Chatterjee, et al.. (2021). Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells. Pharmaceuticals. 14(11). 1126–1126. 19 indexed citations
7.
Chatterjee, Manik, et al.. (2020). Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models. Scientific Reports. 10(1). 18419–18419. 11 indexed citations
8.
Brünnert, Daniela, Marianne Kraus, Thorsten Stühmer, et al.. (2019). Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1666–1676. 13 indexed citations
9.
Stühmer, Thorsten, Anja Mottok, Claus Jürgen Scholz, et al.. (2019). RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS. Haematologica. 105(9). 2316–2326. 13 indexed citations
10.
Rasche, Leo, Emmanuelle Ménoret, Valentina Dubljevic, et al.. (2016). A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement. Clinical Cancer Research. 22(17). 4341–4349. 47 indexed citations
11.
12.
Rasche, Leo, Johannes Duell, Valentina Dubljevic, et al.. (2015). GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6. Haematologica. 100(3). 377–384. 67 indexed citations
13.
Leich, Ellen, Susann Weißbach, Hans‐Ulrich Klein, et al.. (2013). Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules. Blood Cancer Journal. 3(2). e102–e102. 43 indexed citations
14.
Rasche, Leo, Johannes Duell, Manik Chatterjee, et al.. (2013). The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78. PLoS ONE. 8(5). e63414–e63414. 55 indexed citations
15.
Katzer, Astrid, Bülent Polat, Manik Chatterjee, et al.. (2013). Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule. Translational Oncology. 6(2). 169–IN16. 44 indexed citations
16.
Bringmann, Gerhard, Guoliang Zhang, Anastasia Hager, et al.. (2011). Anti-tumoral activities of dioncoquinones B and C and related naphthoquinones gained from total synthesis or isolation from plants. European Journal of Medicinal Chemistry. 46(12). 5778–5789. 33 indexed citations
17.
Stühmer, Thorsten, Manik Chatterjee, Ruth Seggewiss, et al.. (2009). Anti‐myeloma activity of the novel 2‐aminothienopyrimidine Hsp90 inhibitor NVP‐BEP800. British Journal of Haematology. 147(3). 319–327. 14 indexed citations
18.
Bringmann, Gerhard, Torsten Bruhn, Reto Brun, et al.. (2008). Antitumoral and antileishmanial dioncoquinones and ancistroquinones from cell cultures of Triphyophyllum peltatum (Dioncophyllaceae) and Ancistrocladus abbreviatus (Ancistrocladaceae). Phytochemistry. 69(13). 2501–2509. 37 indexed citations
19.
20.
Chatterjee, Manik, et al.. (1959). Determination of potency of unknown samples of crude liver extract on experimental anaemia in mice.. 7. 105–107. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jian Hou Breakdown of academic impact, for papers by A Levitzki Breakdown of academic impact, for papers by Masaki Ri Breakdown of academic impact, for papers by Christin Tse Breakdown of academic impact, for papers by Anna Scuto Breakdown of academic impact, for papers by Stephen K. Tahir Breakdown of academic impact, for papers by Frank D. Böhmer Breakdown of academic impact, for papers by Florian Grebien Breakdown of academic impact, for papers by Paul Nimmer Breakdown of academic impact, for papers by Mariateresa Fulciniti
Rankless by CCL
2026